Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
COBRE RESEARCH SEMINAR SERIES Taking a Tryp with its Twists and Turns Across the Blood-Brain Barrier Human African trypanosomiasis (HAT; commonly called sleeping sickness) has been claimed to be more deadly than other vector-borne diseases such as malaria because death is inevitable if a patient is untreated. The terminal stages of human sleeping sickness are characterized by neurologic signs, progressive coma, seizures and a marked increase in nighttime insomnia and daytime drowsiness (from which the disease gets its name). Sleeping sickness is caused by two subspecies of African trypanosomes (Trypanosoma brucei rhodesiense and T. b. gambiense causing East African and West African sleeping sickness respectively). In classical late stage human sleeping sickness the parasites invade the central nervous system (CNS) and the infected individuals suffer from progressive neurologic involvement with concomitant psychiatric disorders and, if untreated, death. Once inside the brain the parasites are shielded from many of the most effective trypanocidal drugs. Indeed, the brain is probably the source for many relapse infections. When this work was started in 2002, there was a general appreciation that in late stage HAT, a major factor in pathogenesis was the ability of the trypanosome to cross the blood-brain barrier (BBB) and enter the CNS. At that time, very little was known about how trypanosomes achieve passage across the functional unit of the BBB comprised of human brain. In this talk, a review of our progress to delineate the mechanism of African trypanosome traversal across the human BBB at the molecular and cellular levels with the hope that this research that will lead to better therapies against the disease caused by this deadly parasite. Dennis Grab, Ph.D. Associate Professor Department of Pediatrics, Division of Infectious Diseases Johns Hopkins University School of Medicine Baltimore, Maryland Wednesday, July 11, 2012 at 10:15 a.m. John A. Burns School of Medicine, Kaka‘ako Medical Education Building Auditorium (Room 315) For further information, call 692-1654 The Center and its activities are supported by a grant (P20GM103516) from the National Institute of General Medical Sciences, National Institutes of Health.